Skip to content
10-Q

Quarterly Report

BLUEPRINT MEDICINES CORPORATION

0001558370-25-006108

← back to feed
Filed
May 1, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Apr 29, 2025 64.58M sh
Stock Issued Q1 2025 · Mar 31, 2025 0 sh
Stock Issued Q1 2025 · Mar 31, 2024 544.72K sh
Shares Diluted Q1 2025 · Mar 31, 2025 66.53M sh
Shares Diluted Q1 2025 · Mar 31, 2024 63.8M sh
Capex Q1 2025 · Mar 31, 2025 $1.83M
Capex Q1 2025 · Mar 31, 2024 $1.1M
Operating Cash Flow Q1 2025 · Mar 31, 2025 −$54.48M
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$101.51M
Cash And Equivalents Q1 2025 · Mar 31, 2025 $122.25M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $102.01M
Cash And Equivalents Q1 2025 · Mar 31, 2024 $113.33M
Stockholders Equity Q1 2025 · Mar 31, 2025 $342.13M
Stockholders Equity Q1 2025 · Dec 31, 2024 $298.67M
Current Liabilities Q1 2025 · Mar 31, 2025 $250.58M
Current Liabilities Q1 2025 · Dec 31, 2024 $260.8M
Total Liabilities Q1 2025 · Mar 31, 2025 $853.47M
Total Liabilities Q1 2025 · Dec 31, 2024 $881.15M
Current Assets Q1 2025 · Mar 31, 2025 $702.07M
Current Assets Q1 2025 · Dec 31, 2024 $742.68M
Total Assets Q1 2025 · Mar 31, 2025 $1.2B
Total Assets Q1 2025 · Dec 31, 2024 $1.18B
Eps Diluted Q1 2025 · Mar 31, 2025 $0.01
Eps Diluted Q1 2025 · Mar 31, 2024 $1.40
Eps Basic Q1 2025 · Mar 31, 2025 $0.01
Eps Basic Q1 2025 · Mar 31, 2024 $1.45
Sga Expense Q1 2025 · Mar 31, 2025 $95.81M
Sga Expense Q1 2025 · Mar 31, 2024 $83.56M
Rd Expense Q1 2025 · Mar 31, 2025 $91.89M
Rd Expense Q1 2025 · Mar 31, 2024 $88.19M
Net Income Q1 2025 · Mar 31, 2025 $496K
Net Income Q1 2025 · Mar 31, 2024 $89.14M
Cost Of Revenue Q1 2025 · Mar 31, 2025 $2.8M
Cost Of Revenue Q1 2025 · Mar 31, 2024 $3.19M